Mevo Health Tirzepatide Review: Cost, a Verified LegitScript Seal & Honest Verdict (2026)

Mevo Health has a genuine LegitScript seal (#47846386) served directly from LegitScript's own CDN, plus a rare both-molecules, both-routes menu — semaglutide and tirzepatide, each in injection and oral-tablet form. Every fact here comes from the company's own published program.

A verified LegitScript seal

This review checked Mevo Health's LegitScript claim directly and confirmed it's genuine: the seal image is served from static.legitscript.com/seals/47846386.png, LegitScript's own CDN.

What Mevo Health is

Mevo Health (Mevo Health LLC, Delaware) is a direct-pay telehealth platform, offering compounded semaglutide and tirzepatide in both injection and oral-tablet forms — a rare both-routes, both-molecules menu for a DTC platform. It discloses four named board-certified physicians: Wasef, Suppa, Sakla, and Chikando.

What Mevo Health costs

Pricing runs $259/month for all doses at the entry level, with only "as low as" figures shown publicly — no full per-dose itemization is published.

The brand-vs-compounded question

Mevo Health dispenses compounded semaglutide and tirzepatide only — no brand-name pathway. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Mevo Health's real strengths: a genuinely verified LegitScript seal, plus four named board-certified physicians, both injection and oral-tablet options across both molecules, and a published FDA compounded-medication disclaimer. The trade-offs: states served aren't listed on any public page, pharmacy partners aren't named (only "503A U.S. compounding pharmacies" with unlabeled logos), no formal Medical Director role is disclosed, and only "as low as" entry pricing is shown with no full itemization. As with any GLP-1 program, confirm your state's coverage and full dose pricing before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Mevo Health's genuinely verified LegitScript seal and named physician panel are real trust signals this review confirmed directly, and the both-routes, both-molecules menu is a genuine differentiator. Confirm your state's coverage before committing, since it isn't published. For a similarly LegitScript-verified provider with a published state list, compare it against Medro or CoreAge Rx. For a similarly established women's telehealth brand this review found very thin public program detail on, see Nurx. For a virtual primary-care platform with board-certified physicians but a claimed class action this review couldn't verify, see PlushCare. See our best tirzepatide providers ranking for the full field.